SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals is trending as investors respond to significant clinical trial successes, including positive Phase 3 data for donidalorsen and olezarsen, which bolster the company's transition into a fully integrated, commercial-stage biotech. The community is actively discussing these favorable regulatory developments alongside strong insider buying activity and strategic pipeline growth, even as some investors express caution regarding competitive pressures and capital expenditure.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is currently trending following positive phase III results for mezigdomide in multiple myeloma and the announcement of a tumor-activated therapy partnership with Janux Therapeutics. Investors are closely watching these pipeline developments as the company seeks to offset revenue pressures from its legacy drug portfolio while navigating the integration of recent regulatory wins.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as the community eagerly anticipates upcoming quarterly financial results and potential catalysts, such as share buyback updates and long-term re-listing prospects. While the stock continues to see high engagement, discussions remain split between those bullish on its massive store growth and operational efficiency and those cautious of the stock's OTC status and historical volatility.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is currently trending as investors debate the impact of the company's substantial eBay stake and ongoing takeover speculation against a backdrop of stagnant price action. The community remains deeply polarized, with active discussions focused on the potential for a short squeeze, the leadership of Ryan Cohen, and the impact of looming warrant expirations.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid heightened frustration and speculative volatility as investors react to the temporary shelving of the Clarity Act and ongoing debates regarding Ripple's escrow activity and institutional utility. The community remains deeply divided, with many debating whether the current price action represents a final accumulation opportunity before potential institutional adoption or a sign of deeper structural decline.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors debate the impact of ongoing post-pandemic revenue shifts, patent expirations, and oncology pipeline developments on its long-term growth. Community discussion is heavily focused on the stock's dividend sustainability, institutional accumulation patterns, and speculation regarding potential M&A activity within the broader biopharma sector.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently trading in a tight range as investors weigh high valuation concerns against strong institutional interest ahead of earnings. The community remains polarized, with bulls pointing to the company's expanding AIP commercial adoption and government contract growth as key catalysts for a potential post-earnings breakout, while bears argue the stock's high sales multiple leaves it vulnerable to a sharp pullback if results fail to exceed lofty expectations.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing renewed investor interest driven by strong prescription momentum for its oral Wegovy pill, which is outperforming competitor offerings, and optimism surrounding a potential EU approval. Community sentiment remains focused on the company's long-term dominance in the GLP-1 market, with many bulls viewing current price levels as an undervalued entry point despite ongoing legal and competitive pressures from Eli Lilly.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing heightened activity as investors debate the impact of the company's recent authorization to sell up to $5 billion in Bitcoin, a move that has sparked intense disagreement over whether it serves as a necessary capital management strategy or a signal of fundamental weakness. The community remains deeply polarized, with bulls looking toward potential regulatory clarity as a catalyst for growth while bears continue to scrutinize the firms reliance on dilution and its shifting treasury management approach.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending following a high-profile announcement that the company secured a three-year tariff exemption from the U.S. administration by committing to significant domestic manufacturing investments and reduced drug pricing. Community sentiment is focused on the strategic impact of this deal, with investors closely watching for a potential price breakout as the company shifts its primary U.S. trading venue to the NYSE.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jumia Shares Jump As Axian Mulls Buyout of E-Commerce Giant: Report

$JMIA $EMFQ $AADR

https://stocktwits.com/news/equity/markets/jumia-shares-jump-as-axian-mulls-buyout-of-e-commerce-giant/chFW1XRRRC8

Jumia Technologies is exploring potential acquisition talks with Axian Telecom, which recently raised $600 million.